173 related articles for article (PubMed ID: 19616262)
1. Second cancers as competing causes of death after radical prostatectomy.
Froehner M; Koch R; Hakenberg OW; Wirth MP
J Urol; 2009 Sep; 182(3):967-70. PubMed ID: 19616262
[TBL] [Abstract][Full Text] [Related]
2. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
3. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
[TBL] [Abstract][Full Text] [Related]
4. Primary causes of death after permanent prostate brachytherapy.
Bittner N; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Allen ZA; Brammer SG; Moyad M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):433-40. PubMed ID: 18448268
[TBL] [Abstract][Full Text] [Related]
5. Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data.
Abdel-Wahab M; Reis IM; Wu J; Duncan R
Urology; 2009 Oct; 74(4):866-71. PubMed ID: 19628258
[TBL] [Abstract][Full Text] [Related]
6. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Holowaty E; Naglie G
J Natl Cancer Inst; 2005 Oct; 97(20):1525-32. PubMed ID: 16234566
[TBL] [Abstract][Full Text] [Related]
7. Causes of death after radical prostatectomy at a large tertiary center.
Eifler JB; Humphreys EB; Agro M; Partin AW; Trock BJ; Han M
J Urol; 2012 Sep; 188(3):798-801. PubMed ID: 22819416
[TBL] [Abstract][Full Text] [Related]
8. Cause-specific mortality following radical prostatectomy.
Shikanov S; Kocherginsky M; Shalhav AL; Eggener SE
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):106-10. PubMed ID: 22083265
[TBL] [Abstract][Full Text] [Related]
9. Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy?
Froehner M; Koch R; Litz RJ; Hakenberg OW; Wirth MP
BJU Int; 2012 Jul; 110(2):206-10. PubMed ID: 22044591
[TBL] [Abstract][Full Text] [Related]
10. Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgery.
Alibhai SM; Leach M; Warde P
Cancer; 2009 Jan; 115(2):293-302. PubMed ID: 19025976
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer.
Liu L; Coker AL; Du XL; Cormier JN; Ford CE; Fang S
J Surg Oncol; 2008 Jun; 97(7):583-91. PubMed ID: 18381603
[TBL] [Abstract][Full Text] [Related]
12. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
[TBL] [Abstract][Full Text] [Related]
13. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database.
Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
J Urol; 2009 Nov; 182(5):2250-5. PubMed ID: 19758614
[TBL] [Abstract][Full Text] [Related]
14. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden.
Stattin P; Holmberg E; Bratt O; Adolfsson J; Johansson JE; Hugosson J;
J Urol; 2008 Dec; 180(6):2423-9; discussion 2429-30. PubMed ID: 18930283
[TBL] [Abstract][Full Text] [Related]
15. Secondary cancer and relapse rates following radical prostatectomy for prostate-confined cancer.
Wesley D; Cox HF
J Insur Med; 2007; 39(4):242-50. PubMed ID: 18522141
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy.
Shepard DR; Dreicer R; Garcia J; Elson P; Magi-Galluzzi C; Raghavan D; Stephenson AJ; Klein EA
J Urol; 2009 Apr; 181(4):1672-7; discussion 1677. PubMed ID: 19230915
[TBL] [Abstract][Full Text] [Related]
17. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
Glickman L; Godoy G; Lepor H
J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
[TBL] [Abstract][Full Text] [Related]
18. Interaction between age and comorbidity as predictors of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
J Urol; 2008 May; 179(5):1823-9; discussion 1829. PubMed ID: 18355873
[TBL] [Abstract][Full Text] [Related]
19. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M
Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762
[TBL] [Abstract][Full Text] [Related]
20. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
Otto SJ; Schröder FH; de Koning HJ
J Clin Oncol; 2006 Sep; 24(25):4184-9. PubMed ID: 16943535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
